Pacira Biosciences Study Finds Iovera° Superior to Radiofrequency Ablation for Chronic Low Back Pain
Pacira BioSciences Inc. announced a study showing iovera° cryoneurolysis is more effective than radiofrequency ablation for chronic low back pain. The 12-month study with 30 patients found significant pain reduction and improved functional outcomes with iovera°. Fewer patients needed additional spine injections, and no adverse events were reported. Results were published in Pain Physician.
Pacira BioSciences Inc. announced results from a 12-month randomized pilot study evaluating the safety and effectiveness of iovera° cryoneurolysis compared to radiofrequency ablation (RFA) for chronic low back pain. The study, which involved 30 patients and was published in the journal Pain Physician, reported that iovera° was associated with significant improvements in pain reduction and functional outcomes. Additionally, fewer patients treated with iovera° required additional spine injections after 180 days, and no treatment-related adverse events were observed. The results have already been published and presented in Pain Physician. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacira Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9595044-en) on December 02, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
